Joel H. Kaufman
2019
In 2019, Joel H. Kaufman earned a total compensation of $274.9K as Chief Business Officer at Navidea Biopharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $39,379 |
---|---|
Option Awards | $4,882 |
Salary | $225,000 |
Other | $5,600 |
Total | $274,861 |
Kaufman received $225K in salary, accounting for 82% of the total pay in 2019.
Kaufman also received $39.4K in non-equity incentive plan, $4.9K in option awards and $5.6K in other compensation.
Rankings
In 2019, Joel H. Kaufman's compensation ranked 13,088th out of 13,971 executives tracked by ExecPay. In other words, Kaufman earned more than 6.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,088 | 6th |
Manufacturing | 5,322 | 7th |
Chemicals And Allied Products | 2,080 | 6th |
Drugs | 1,787 | 5th |
In Vitro and In Vivo Diagnostic Substances | 71 | 8th |
Kaufman's colleagues
We found two more compensation records of executives who worked with Joel H. Kaufman at Navidea Biopharmaceuticals in 2019.
News
Navidea Biopharmaceuticals CEO Jed Latkin's 2021 pay rises 10% to $1.3M
October 24, 2022
Navidea Biopharmaceuticals CEO Jed Latkin's 2020 pay jumps 66% to $1.2M
August 2, 2021
Navidea Biopharmaceuticals CEO Jed Latkin's 2019 pay rises 16% to $740K
July 31, 2020
Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
June 28, 2019